People · Operator
Named in public records as an officer, director or promoter · active 2020–2024 · Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elastrin Therapeutics, Inc. | — | Biotechnology | Series A | $13.3M | $2.4M | 2021 |
| TGen Tech, LLC | — | Software / Tech | Pre-Seed | $600K | $20.4M | 2020 |
Naren Vyavahare at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Naren Vyavahare on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Burgermeister | 1 | 2 |
| Matthias Breugelmans | 1 | 1 |
| Klaus-Dieter Langner | 1 | 1 |
| Ajay Houde | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.